Provided by Tiger Trade Technology Pte. Ltd.

Korro Bio, Inc.

13.83
+0.75505.78%
Volume:22.77K
Turnover:310.62K
Market Cap:203.58M
PE:-1.40
High:13.90
Open:13.14
Low:13.14
Close:13.07
52wk High:55.89
52wk Low:5.20
Shares:14.73M
Float Shares:10.47M
Volume Ratio:0.80
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.8800
EPS(LYR):-12.4806
ROE:-97.69%
ROA:-27.95%
PB:1.97
PE(LYR):-1.11

Loading ...

Korro Bio initiated with an Outperform at LifeSci Capital

TIPRANKS
·
May 29

Analysts Are Bullish on Top Healthcare Stocks: Korro Bio (KRRO), Veeva Systems (VEEV)

TIPRANKS
·
May 28

Korro Bio CEO Ram Aiyar to present at Jefferies Global Healthcare Conference

Reuters
·
May 27

Korro Bio (KRRO) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 27

Korro Bio selects KRRO-111 as development candidate

TIPRANKS
·
May 19

Korro Bio Advances KRRO-111 for Alpha-1 Deficiency

TIPRANKS
·
May 19

Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

GlobeNewswire
·
May 19

Korro Bio, Inc. : H.c. Wainwright Cuts Target Price to $15 From $20

THOMSON REUTERS
·
May 19

Korro Bio Initiated at Buy by Citigroup

Dow Jones
·
May 18

Citigroup Initiates Korro Bio at Buy With $21 Price Target

MT Newswires Live
·
May 18

Korro Bio initiated with a Buy at Citi

TIPRANKS
·
May 18

Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Korro Bio (KRRO)

TIPRANKS
·
May 18

Korro Bio publishes ASGCT 2026 presentation on GalNAc-conjugated RNA editing in AATD models

Reuters
·
May 16

Korro Bio grants new hire option for 3,000 shares at $11.2 each

Reuters
·
May 16

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 16

JonesResearch upgrades ‘fast-follower’ Korro Bio to Buy

TIPRANKS
·
May 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: CareCloud (CCLD) and Korro Bio (KRRO)

TIPRANKS
·
May 08

Korro Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Korro Bio Q1 EPS $(1.69) Beats $(2.17) Estimate

Benzinga Earnings
·
May 07

Korro Bio posts corporate presentation on RNA-editing genetic medicines pipeline

Reuters
·
May 07